No Data
No Data
Here's Why We're Watching Noxopharm's (ASX:NOX) Cash Burn Situation
Noxopharm Launches Pioneering Lupus Drug Trial
Noxopharm's CRO-67 Shows Promise in Pancreatic Cancer
Noxopharm Advances Sofra Platform Commercialisation With Multiple Material Transfer Agreements
Noxopharm Joins Alliance for MRNA Medicines; Shares Up Nearly 7%
Noxopharm and UniSA Receive Tour De Cure Grant for Brain Cancer Research | ASX:NOX, OTC:NOXOF
No Data